ONESOURCE SPECL PHARMA L Share Price

NSE: ONESOURCE

₹ 1,649.00

-₹5.30 (-0.32%)

Last updated 24 Jul, 2026, 15:29 IST

ONESOURCE SPECL PHARMA L Share Price Today

As of 25 Jul 2026, ONESOURCE SPECL PHARMA L share price is ₹1,649.00. The stock opened at ₹1,637.00, compared to its previous close of ₹1,654.30. During today's trading session, ONESOURCE SPECL PHARMA L share price moved in the range of ₹1,631.90 to ₹1,663.20, with an average price of ₹1,647.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,057.00 and a high of ₹2,026.50. On the performance front, ONESOURCE SPECL PHARMA L share price has increased by 15.46% over the last six months and is down 16.54% on a year-on-year basis.

₹1,631.90

0.32% down today

₹1,663.20

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 99.69% QoQ

Latest Earning

Net Profit TrendUp by 105.19% QoQ

Latest Earning

Revenue TrendUp by 45.88% QoQ

Stock Performance

OutperformingBeat Nifty by 5.33 % in last 1 month

Shareholding Pattern

PromoterPromoter decreased stake by 0.02%

Shareholding Pattern

DIIDII decreased stake by 0.77%

Shareholding Pattern

FIIFII increased stake by 9.69%

ONESOURCE SPECL PHARMA L Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,21,977-₹78,023 (-15.60%)

3 Year

₹5,21,340+₹21,340 (+4.27%)

5 Year

₹5,21,340+₹21,340 (+4.27%)

₹1,323.50₹1,985.10

Circuit Low

Circuit High

₹1,057.00₹2,026.50

52-Week Low

52-Week High

Circuit

₹1,323.50

₹1,985.10

52-week

₹1,057.00

₹2,026.50

Mkt Cap Cr

18,960.10

P/E

-256.74

P/B

3.25

ROE

-1.10%

D/E

0.25

ROCE

0.55%

Div. Yield

0.00%

EPS(TTM)

1.85

Turnover

0.17

EV/EBITDA

65.86

Net Margin

0.00%

Op. Margin

0.00%

ROA

-0.90%

Quick Ratio

0.00

Curr. Ratio

1.82

Mkt Cap Cr

18,960.10

P/E

-256.74

P/B

3.25

ROE

-1.10%

D/E

0.25

ROCE

0.55%

Div. Yield

0.00%

EPS(TTM)

1.85

Turnover

0.17

EV/EBITDA

65.86

Net Margin

0.00%

Op. Margin

0.00%

ROA

-0.90%

Quick Ratio

0.00

Curr. Ratio

1.82

Based on fundamentals, this stock's

Performance

Excellent

OneSource Speci. outperforming all market indices

Valuation

Overvalued

OneSource Speci. appears overvalued compared to its peers

Earnings

Neutral

OneSource Speci. earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,68,842.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,93,860.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Torrent Pharmaceuticals	1,92,687.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,12,593.00	33.55	3.27	11.27%	0.00	14.95%	423.36	0.93%	0.44	43.52
Zydus Lifesciences	1,11,082.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,09,553.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Mankind Pharma	1,05,607.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	97,364.90	30.58	2.56	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	88,508.40	25.27	2.34	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	84,727.30	60.26	10.10	18.21%	0.45	16.70%	10.19	0.20%	0.97	13.72

ONESOURCE SPECL PHARMA L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹1,444.85	₹171.92	₹38.71	₹132.13
Other Income	₹17.47	₹4.23	₹2.69	₹3.77
Total Revenue	₹1,462.33	₹176.14	₹41.41	₹135.90
Total Expenses	₹1,418.55	₹425.90	₹312.63	₹367.16
Profit Before Tax	-₹67.07	-₹365.70	-₹415.65	-₹231.27
Tax	-₹49.79	₹0.00	₹0.00	-₹0.11
Profit After Tax	-₹17.28	-₹365.70	-₹415.65	-₹231.16
EPS - Basic	-₹1.63	-₹94.15	-₹200.87	-₹65.25
EPS - Diluted	-₹1.63	-₹94.15	-₹200.87	-₹65.25

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	-₹67.76	-₹391.17	-₹799.83	-₹231.27
Income before WC changes	₹359.04	-₹103.08	-₹195.51	-₹83.81
Change in Assets	-₹287.99	-₹77.49	-₹36.86	-₹370.13
Change in Liabilities	-₹131.89	₹73.36	₹58.56	₹37.98
Change in WC	-₹419.89	-₹4.13	₹21.70	-₹332.15
Cash flow from Operations	-₹67.85	-₹107.21	-₹162.88	-₹415.89
Cash flow from Investing	-₹201.08	₹510.55	-₹67.72	-₹691.60
Cash flow from Financing	₹412.01	-₹390.54	₹118.32	₹1,161.96
Total Cash Flow	₹143.07	₹12.79	-₹112.28	₹54.47
Cash (Start of the year)	₹22.26	₹9.47	₹121.76	₹67.29
Cash (End of the year)	₹165.36	₹22.26	₹9.47	₹121.76

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹6,464.06	₹1,132.23	₹1,780.40	₹1,931.26
Current Assets	₹1,086.18	₹176.38	₹228.40	₹511.10
Total Assets	₹7,550.24	₹1,308.61	₹2,008.81	₹2,442.36
Current Liabilities	₹1,113.56	₹630.59	₹865.22	₹808.69
Net Current Asset	-₹27.38	-₹454.21	-₹636.81	-₹297.60
Non-Current Liabilities	₹556.10	₹282.31	₹358.14	₹621.19
Equity Capital	₹5,880.58	₹395.71	₹785.45	₹1,012.48
Total Equity & Liabilities	₹7,550.24	₹1,308.61	₹2,008.81	₹2,442.36

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹1,299.59	₹171.92	₹38.71	₹132.13
Other Income	₹17.68	₹4.23	₹2.70	₹5.86
Total Revenue	₹1,317.27	₹176.14	₹41.42	₹137.99
Total Expenses	₹1,226.48	₹425.14	₹312.56	₹367.73
Profit Before Tax	-₹21.46	-₹364.93	-₹429.55	-₹229.74
Tax	-₹41.46	₹0.00	₹0.00	₹0.00
Profit After Tax	₹20.00	-₹364.93	-₹429.55	-₹229.74
EPS - Basic	₹1.75	-₹93.97	-₹200.69	-₹58.76
EPS - Diluted	₹1.75	-₹93.97	-₹200.69	₹0.00

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	-₹22.15	-₹390.40	-₹799.11	-₹229.74
Income before WC changes	₹262.52	-₹102.33	-₹194.18	-₹83.00
Change in Assets	-₹303.13	-₹79.79	-₹37.15	-₹370.67
Change in Liabilities	₹0.23	₹73.13	₹55.70	₹34.00
Change in WC	-₹302.90	-₹6.66	₹18.55	-₹336.67
Cash flow from Operations	-₹47.28	-₹108.99	-₹164.70	-₹419.66
Cash flow from Investing	-₹300.04	₹505.99	-₹65.68	-₹684.54
Cash flow from Financing	₹417.22	-₹384.22	₹118.32	₹1,158.75
Total Cash Flow	₹69.90	₹12.78	-₹112.06	₹54.55
Cash (Start of the year)	₹22.19	₹9.41	₹121.47	₹66.92
Cash (End of the year)	₹92.09	₹22.19	₹9.41	₹121.47

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹6,366.58	₹1,132.16	₹1,780.23	₹1,933.33
Current Assets	₹1,023.88	₹176.42	₹228.21	₹511.67
Total Assets	₹7,390.46	₹1,308.58	₹2,008.44	₹2,445.00
Current Liabilities	₹1,069.48	₹628.52	₹863.59	₹808.31
Net Current Asset	-₹45.60	-₹452.10	-₹635.38	-₹296.64
Non-Current Liabilities	₹400.88	₹282.31	₹358.14	₹621.18
Equity Capital	₹5,920.10	₹397.74	₹786.71	₹1,015.51
Total Equity & Liabilities	₹7,390.46	₹1,308.58	₹2,008.44	₹2,445.00

* All values are in INR Crore

Qty

Bid

Ask

Qty

1653.9

Bid Total: 0

Ask Total: 28

Buy orders: 0%

Sell orders: 100%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bullish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

49.36

Neutral

ATR (14)

73.46

Neutral

STOCH(9,6)

56.11

Neutral

STOCH RSI (14)

50.28

Neutral

ADX(9)

12.66

Bullish

UO(9)

57.49

Neutral

ROC(12)

1.69

Bullish

WillR(14)

-30.72

Neutral

Period

Simple value

Exponential vaue

1664.82

1660.35

10D

1656.13

1656.08

20D

1644.91

1654.35

50D

1703.36

1659.58

100D

1616.16

1639.35

About ONESOURCE SPECL PHARMA L

ISIN

INE013P01021

Sector Market Cap

₹ 18,960.1 Cr

OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.

ONESOURCE SPECL PHARMA L Financial Highlights

Revenue: ONESOURCE SPECL PHARMA L reported revenue of ₹1,436.61 crore in FY26 vs ₹1,462.32 crore in FY25. It showed a decrease of 1.76% on a yearly basis.
Operating Profit: ONESOURCE SPECL PHARMA L reported an operating loss of ₹91.96 crore in FY26 vs ₹67.07 crore in FY25. It showed a decrease of 37.11% on a year-on-year basis.
Net Profit: ONESOURCE SPECL PHARMA L reported a net loss of ₹73.80 crore in FY26 vs ₹17.97 crore in FY25. It showed a decrease of 310.68% on a yearly basis.

ONESOURCE SPECL PHARMA L Quarterly Result Highlights

ONESOURCE SPECL PHARMA L reported revenue of ₹452.82 crore in Jun 2026, compared with ₹430.31 crore in Mar 2026, representing an increase of 5.23% on a quarter-on-quarter (QoQ) basis.
ONESOURCE SPECL PHARMA L reported an operating profit of ₹20.29 crore in Jun 2026, compared with ₹0.29 crore in Mar 2026, representing an increase of 7,096.55% on a quarter-on-quarter (QoQ) basis.
ONESOURCE SPECL PHARMA L reported a profit of ₹25.00 crore in Jun 2026, compared with ₹4.60 crore in Mar 2026, reflecting an increase of 443.48% on a QoQ basis.
The earnings per share (EPS) of ONESOURCE SPECL PHARMA L stood at ₹1.63 during Jun 2026.